Michelle Y Cheng, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office at (408) 445-4010 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A137986 · Current
Licensed to practise in California · since 2015 · expires 2027-06-30 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$139,451
Medicare paid this office $139,451 for 516 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 333 | $32,561 | $70 |
| Return visit (30+ min) | 148 | $23,259 | $113 |
| Destruction of precancer skin growth, 1 growth | 232 | $16,217 | $49 |
| Destruction of skin growth, 1-14 growths | 121 | $15,382 | $107 |
| Biopsy of related skin growth, first growth | 113 | $11,890 | $87 |
See all 14 services
| Short return visit (20+ min) | 333 | $32,561 | $70 |
| Return visit (30+ min) | 148 | $23,259 | $113 |
| Destruction of precancer skin growth, 1 growth | 232 | $16,217 | $49 |
| Destruction of skin growth, 1-14 growths | 121 | $15,382 | $107 |
| Biopsy of related skin growth, first growth | 113 | $11,890 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 183 | $8,033 | $7 |
| New patient visit (30+ min) | 71 | $6,105 | $86 |
| Application of ultraviolet light to skin | 22 | $5,610 | $27 |
| New patient visit (45+ min) | 30 | $4,116 | $137 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $3,015 | $168 |
| Biopsy of related skin growth, each additional growth | 28 | $1,849 | $46 |
| Punch biopsy, first skin growth | 11 | $1,660 | $119 |
| Injection into skin growth, 1-7 growths | 13 | $1,083 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $21 | None |
Procedures Medicare counted
| Removal of skin lesions | 783 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 232 | More than 87% of doctors who do this |
Who their Medicare patients are
516 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 14% · Women 54% · Also on Medicaid 6% · Health risk score 0.84. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 60% · Diabetes 18% · Coronary heart disease 18% · Chronic kidney disease 17% · Cancer 17% · Atrial fibrillation 15% · Depression 13% · Heart failure 9% · COPD 6% · Stroke 5% · Dementia 4%.
The office billed $520,150, Medicare allowed $197,942 and paid $139,451; for 2,960 services of 44 kinds; $331 of it was for drugs given in the office and $139,121 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 516 | 2,960 | 75 | 0.84 | $520,150 | $139,451 |
| 2023 | 554 | 2,933 | 76 | 0.84 | $474,054 | $136,090 |
| 2022 | 458 | 1,876 | 76 | 0.89 | $342,145 | $99,071 |
| 2021 | 391 | 1,508 | 77 | 0.97 | $326,914 | $100,476 |
| 2020 | 91 | 246 | 76 | 0.93 | $57,654 | $17,380 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 368 | $42,039 | $76 |
| Destruction of skin growth, 1-14 growths | 138 | $17,953 | $112 |
| Destruction of precancer skin growth, 1 growth | 193 | $14,088 | $50 |
| Biopsy of related skin growth, first growth | 117 | $12,193 | $90 |
| Return visit (30+ min) | 73 | $10,828 | $103 |
| Destruction of precancer skin growth, 2-14 growths | 152 | $6,950 | $7 |
| New patient visit (30+ min) | 87 | $6,727 | $77 |
| New patient visit (45+ min) | 21 | $2,878 | $137 |
| Application of ultraviolet light to skin | 27 | $2,756 | $27 |
| Biopsy of related skin growth, each additional growth | 30 | $2,128 | $51 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,065 | $148 |
| Punch biopsy, first skin growth | 14 | $1,891 | $135 |
| Short return visit | 27 | $1,365 | $51 |
| New patient visit (15+ min) | 11 | $618 | $56 |
2022: 12 services
| Short return visit (20+ min) | 242 | $23,679 | $73 |
| Return visit (30+ min) | 75 | $10,998 | $110 |
| Destruction of skin growth, 1-14 growths | 82 | $9,799 | $108 |
| Biopsy of related skin growth, first growth | 81 | $8,491 | $92 |
| Destruction of precancer skin growth, 1 growth | 115 | $7,901 | $52 |
| New patient visit (30+ min) | 78 | $6,774 | $87 |
| New patient visit (45+ min) | 28 | $3,645 | $130 |
| Destruction of precancer skin growth, 2-14 growths | 99 | $3,422 | $7 |
| Application of ultraviolet light to skin | 26 | $3,067 | $27 |
| Punch biopsy, first skin growth | 18 | $2,410 | $127 |
| Biopsy of related skin growth, each additional growth | 23 | $1,562 | $49 |
| Short return visit | 17 | $815 | $45 |
2021: 10 services
| Short return visit (20+ min) | 167 | $18,485 | $82 |
| Return visit (30+ min) | 99 | $15,962 | $111 |
| New patient visit (30+ min) | 111 | $10,942 | $99 |
| Biopsy of related skin growth, first growth | 88 | $10,653 | $101 |
| Destruction of skin growth, 1-14 growths | 70 | $9,321 | $115 |
| Destruction of precancer skin growth, 1 growth | 114 | $7,619 | $50 |
| New patient visit (45+ min) | 53 | $6,662 | $126 |
| Punch biopsy, first skin growth | 25 | $3,466 | $139 |
| Destruction of precancer skin growth, 2-14 growths | 90 | $2,916 | $7 |
| Biopsy of related skin growth, each additional growth | 34 | $2,560 | $54 |
2020: 7 services
| Return visit (30+ min) | 35 | $4,451 | $104 |
| New patient visit (30+ min) | 24 | $2,143 | $89 |
| Biopsy of related skin growth, first growth | 12 | $1,455 | $97 |
| Short return visit (20+ min) | 18 | $1,360 | $68 |
| New patient visit (15+ min) | 18 | $1,134 | $63 |
| Destruction of precancer skin growth, 1 growth | 17 | $1,080 | $54 |
| Destruction of precancer skin growth, 2-14 growths | 13 | $344 | $6 |
Drugs they prescribed that Part D paid
$314,348
Pharmacies billed $314,348 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 706) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
634 generic and 72 brand-name prescriptions · $314,348 in drug cost · 41 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 54 | $206,766 | $3,829 |
| Fluorouracil | 38 | $2,677 | $70 |
| Ketoconazole | 105 | $2,191 | $21 |
| Doxycycline Monohydrate | 28 | $1,533 | $55 |
| Fluocinonide | 40 | $1,055 | $26 |
See all 16 drugs
| Dupixent | 54 | $206,766 | $3,829 |
| Fluorouracil | 38 | $2,677 | $70 |
| Ketoconazole | 105 | $2,191 | $21 |
| Doxycycline Monohydrate | 28 | $1,533 | $55 |
| Fluocinonide | 40 | $1,055 | $26 |
| Clobetasol Propionate | 24 | $913 | $38 |
| Hydroxychloroquine Sulfate | 15 | $853 | $57 |
| Metronidazole | 17 | $707 | $42 |
| Finasteride | 23 | $630 | $27 |
| Triamcinolone Acetonide | 91 | $602 | $7 |
| Clindamycin Phosphate | 17 | $474 | $28 |
| Valacyclovir | 22 | $281 | $13 |
| Mupirocin | 37 | $261 | $7 |
| Pentoxifylline | 12 | $181 | $15 |
| Hydrocortisone | 33 | $173 | $5 |
| Metformin | 13 | $135 | $10 |
Year by year
| 2024 | 706 | 240 | 0% (0) | 10% | $314,348 |
| 2023 | 638 | 237 | 0% (0) | 8% | $195,806 |
| 2022 | 511 | 193 | 0% (0) | 11% | $191,186 |
| 2021 | 450 | 178 | 0% (0) | 12% | $122,742 |
| 2020 | 74 | 46 | 0% (0) | None | $3,999 |
| 2019 | 62 | 29 | 0% (0) | None | $3,913 |
| 2018 | 37 | 15 | 0% (0) | None | $3,292 |
| 2017 | 39 | 12 | 0% (0) | None | $34,550 |
| 2015 | 21 | 14 | 0% (0) | None | $1,062 |
| 2014 | 21 | 13 | 0% (0) | None | $770 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Dupixent | 35 | $131,530 | $3,758 |
| Fluorouracil | 31 | $3,091 | $100 |
| Fluocinonide | 45 | $2,356 | $52 |
| Doxycycline Monohydrate | 36 | $1,766 | $49 |
| Ketoconazole | 76 | $1,749 | $23 |
| Clobetasol Propionate | 26 | $1,514 | $58 |
| Triamcinolone Acetonide | 109 | $1,071 | $10 |
| Doxycycline Hyclate | 18 | $1,001 | $56 |
| Hydroxychloroquine Sulfate | 13 | $925 | $71 |
| Clindamycin Phosphate | 16 | $918 | $57 |
| Mupirocin | 48 | $436 | $9 |
| Hydrocortisone | 49 | $338 | $7 |
| Prednisone | 18 | $117 | $7 |
2022: 13 drugs
| Dupixent | 19 | $63,393 | $3,336 |
| Xolair | 17 | $45,088 | $2,652 |
| Doxycycline Monohydrate | 39 | $2,204 | $57 |
| Fluocinonide | 38 | $1,884 | $50 |
| Clobetasol Propionate | 19 | $1,550 | $82 |
| Triamcinolone Acetonide | 112 | $1,503 | $13 |
| Fluorouracil | 16 | $1,382 | $86 |
| Clindamycin Phosphate | 22 | $1,306 | $59 |
| Ketoconazole | 48 | $820 | $17 |
| Betamethasone Diprop Augmented | 12 | $743 | $62 |
| Ciclopirox | 12 | $538 | $45 |
| Mupirocin | 38 | $401 | $11 |
| Hydrocortisone | 14 | $93 | $7 |
2021: 9 drugs
| Betamethasone Dipropionate | 21 | $3,920 | $187 |
| Betamethasone Diprop Augmented | 22 | $1,723 | $78 |
| Triamcinolone Acetonide | 141 | $1,697 | $12 |
| Ketoconazole | 35 | $1,337 | $38 |
| Doxycycline Monohydrate | 25 | $1,265 | $51 |
| Clobetasol Propionate | 11 | $798 | $73 |
| Fluocinonide | 14 | $761 | $54 |
| Mupirocin | 32 | $356 | $11 |
| Hydrocortisone | 29 | $222 | $8 |
2020: 1 drug
| Triamcinolone Acetonide | 25 | $243 | $10 |
Money from drug and device companies
$2,795 in 2025
| 2025 | 14 | 104 | None | $2,795 |
| 2024 | 11 | 50 | None | $1,479 |
| 2021 | 1 | 1 | None | $103 |
| 2020 | 1 | 1 | None | $125 |
| 2019 | 7 | 9 | None | $753 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $1,123 | 34 payments
|
| Galderma Laboratories L.P. | Nemluvio | $346 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $278 | 17 payments
|
| Incyte | Opzelura | $219 | 8 payments
|
| Lilly USA | Taltz | $205 | 8 payments
|
| Genzyme | Dupixent | $190 | 6 payments
|
See all 104 published payments
| Galderma Laboratories L.P. | Meals · 2025-12-18 | Nemluvio | $37 |
| Regeneron Healthcare Solutions | Meals · 2025-12-17 | Dupixent | $21 |
| Galderma Laboratories L.P. | Meals · 2025-12-17 | Nemluvio | $14 |
| Galderma Laboratories L.P. | Meals · 2025-12-16 | Nemluvio | $10 |
| Incyte | Meals · 2025-12-10 | Opzelura | $12 |
| Abbvie | Meals · 2025-12-04 | Skyrizi | $23 |
| Janssen Biotech | Meals · 2025-12-03 | Tremfya | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-11-22 | Dupixent | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-11-21 | Dupixent | $16 |
| LEO Pharma | Meals · 2025-11-18 | Adbry | $20 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $10 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $14 |
| Incyte | Meals · 2025-11-14 | Opzelura | $22 |
| Ucb | Meals · 2025-11-08 | Bimzelx | $28 |
| Abbvie | Meals · 2025-11-07 | Skyrizi | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-11-05 | Dupixent | $11 |
| Incyte | Meals · 2025-11-05 | Opzelura | $30 |
| Pfizer | Meals · 2025-11-05 | Cibinqo | $27 |
| Janssen Biotech | Meals · 2025-10-29 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-10-28 | Tremfya | $23 |
| Galderma Laboratories L.P. | Meals · 2025-10-27 | Nemluvio | $26 |
| Abbvie | Meals · 2025-10-25 | Skyrizi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-10-22 | Dupixent | $28 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $24 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $6 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $1 |
| Lilly USA | Meals · 2025-10-07 | Taltz | $30 |
| Incyte | Meals · 2025-10-03 | Opzelura | $19 |
| Ucb | Meals · 2025-09-29 | Bimzelx | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-09-24 | Dupixent | $13 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $32 |
| Regeneron Healthcare Solutions | Education · 2025-09-23 | Dupixent | $5 |
| Abbvie | Meals · 2025-09-20 | Rinvoq | $19 |
| Janssen Biotech | Meals · 2025-09-19 | Tremfya | $146 |
| Genzyme | Meals · 2025-09-19 | Ayvakit | $32 |
| Incyte | Meals · 2025-09-17 | Opzelura | $72 |
| Galderma Laboratories L.P. | Meals · 2025-09-17 | Nemluvio | $28 |
| Janssen Biotech | Meals · 2025-09-15 | Tremfya | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-09-13 | Dupixent | $23 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $16 |
| Incyte | Meals · 2025-09-05 | Opzelura | $9 |
| Janssen Biotech | Meals · 2025-09-02 | Tremfya | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-08-30 | Dupixent | $11 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $22 |
| Pfizer | Meals · 2025-08-26 | Cibinqo | $28 |
| Janssen Biotech | Meals · 2025-08-20 | Tremfya | $14 |
| Incyte | Meals · 2025-08-20 | Opzelura | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-08-16 | Dupixent | $10 |
| Lilly USA | Meals · 2025-08-15 | Taltz | $34 |
| Abbvie | Meals · 2025-08-09 | Skyrizi | $24 |
| Genzyme | Meals · 2025-08-07 | Dupixent | $20 |
| Galderma Laboratories L.P. | Meals · 2025-08-02 | Nemluvio | $35 |
| Janssen Biotech | Meals · 2025-07-30 | Tremfya | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-07-18 | Dupixent | $15 |
| Janssen Biotech | Meals · 2025-07-15 | Tremfya | $35 |
| Lilly USA | Meals · 2025-07-11 | Taltz | $32 |
| Janssen Biotech | Meals · 2025-07-08 | Tremfya | $19 |
| Pfizer | Meals · 2025-07-08 | Cibinqo | $26 |
| Janssen Biotech | Meals · 2025-07-01 | Tremfya | $34 |
| Janssen Biotech | Meals · 2025-06-24 | Tremfya | $112 |
| Genzyme | Meals · 2025-06-24 | Dupixent | $29 |
| Janssen Biotech | Meals · 2025-06-19 | Tremfya | $35 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $37 |
| Lilly USA | Meals · 2025-06-13 | Taltz | $23 |
| Galderma Laboratories L.P. | Meals · 2025-06-07 | Nemluvio | $21 |
| Galderma Laboratories L.P. | Meals · 2025-05-31 | Nemluvio | $13 |
| Janssen Biotech | Meals · 2025-05-28 | Tremfya | $143 |
| Janssen Biotech | Meals · 2025-05-27 | Tremfya | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-05-23 | Dupixent | $15 |
| Lilly USA | Meals · 2025-05-20 | Taltz | $28 |
| Galderma Laboratories L.P. | Meals · 2025-05-19 | Nemluvio | $19 |
| Galderma Laboratories L.P. | Meals · 2025-05-16 | Nemluvio | $29 |
| Pfizer | Meals · 2025-05-15 | Cibinqo | $20 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $37 |
| Genzyme | Meals · 2025-04-29 | Dupixent | $33 |
| Lilly USA | Meals · 2025-04-28 | Taltz | $25 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-28 | Cabtreo | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-04-26 | Dupixent | $15 |
| Galderma Laboratories L.P. | Meals · 2025-04-23 | Nemluvio | $15 |
| Janssen Biotech | Meals · 2025-04-22 | Tremfya | $29 |
| Janssen Biotech | Meals · 2025-04-15 | Tremfya | $26 |
| Galderma Laboratories L.P. | Meals · 2025-04-09 | Nemluvio | $36 |
| Lilly USA | Meals · 2025-04-01 | Taltz | $7 |
| Lilly USA | Meals · 2025-04-01 | Taltz | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-03-28 | Dupixent | $11 |
| Regeneron Healthcare Solutions | Education · 2025-03-27 | Dupixent | $7 |
| Novartis Pharmaceuticals | Meals · 2025-03-26 | Cosentyx | $31 |
| Galderma Laboratories L.P. | Meals · 2025-03-26 | Nemluvio | $31 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-03-20 | Cabtreo | $22 |
| Janssen Biotech | Meals · 2025-03-18 | Tremfya | $31 |
| Organon | Meals · 2025-03-17 | Hadlima | $34 |
| Sun Pharmaceutical Industries | Meals · 2025-03-13 | Winlevi | $28 |
| Incyte | Meals · 2025-03-12 | Opzelura | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-03-10 | Dupixent | $32 |
| Genzyme | Meals · 2025-03-07 | Dupixent | $34 |
| Janssen Biotech | Meals · 2025-03-04 | Tremfya | $18 |
| Janssen Biotech | Meals · 2025-03-04 | Tremfya | $2 |
| Galderma Laboratories L.P. | Meals · 2025-02-28 | Nemluvio | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-02-12 | Dupixent | $28 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $42 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $121 |
See earlier years (2024, 2021, 2020, 2019)
2024: $1,479
| Janssen Biotech | Tremfya | $481 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $253 | 9 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $240 | 9 payments
|
| Genzyme | Dupixent | $112 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $104 | 4 payments
|
| Lilly USA | Taltz | $95 | 5 payments
|
| Abbvie | Rinvoq | $60 | 2 payments
|
| Incyte | Opzelura | $48 | 2 payments
|
| Ucb | Bimzelx | $35 | 1 payment
|
| Pfizer | Litfulo | $25 | 1 payment
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
2021: $103
| Amgen | Otezla | $103 | 1 payment
|
2020: $125
| Genentech USA | Erivedge | $125 | 1 payment
|
2019: $753
| AbbVie | Skyrizi | $124 | 1 payment
|
| Genzyme | Dupixent | $124 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $122 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $101 | 1 payment
|
| Amgen | Enbrel | $100 | 1 payment
|
| Lilly USA | Taltz | $92 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $91 | 2 payments
|
Professional record
- NPI
- 1467871590
- Licence
- CA A137986California A137986: Current · expires 2027-06-30
- Trained
- University of Pittsburgh School of Medicine, 2014
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-16
- NPI last updated
- 2020-08-14
- NPI record certified
- 2020-08-14
This is when the NPI record was last certified, not a medical board exam.